SERIES B COMMON STOCK PURCHASE WARRANT BIONANO GENOMICS, INC.Bionano Genomics, Inc. • July 8th, 2024 • Laboratory analytical instruments • New York
Company FiledJuly 8th, 2024 Industry JurisdictionTHIS SERIES B COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the Stockholder Approval Date (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on the earlier of (i) the five (5) year anniversary of the Stockholder Approval Date and (ii) six (6) months following the later of (a) the date of the public announcement by the Company of the occurrence of the Series B Milestone Event and (b) the Stockholder Approval Date (the earlier of such dates, the “Termination Date”) but not thereafter, to subscribe for and purchase from Bionano Genomics, Inc., a Delaware corporation (the “Company”), up to ______ shares (as subject to adjustment hereunder, the “Warrant Shares”) of the Company’s Common Stock. The purchase price of one share of Common Stock under thi
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • July 8th, 2024 • Bionano Genomics, Inc. • Laboratory analytical instruments • New York
Contract Type FiledJuly 8th, 2024 Company Industry JurisdictionThis Securities Purchase Agreement (this “Agreement”) is dated as of July 4, 2024, between Bionano Genomics, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).